. . . . . . . "[Taking a broad-based approach by using a number of small-molecule inhibitors of various mitogenic/survival pathways, we found that only treatment of non-small cell lung cancer (NSCLC) cell lines with the phosphoinositide 3-kinase (PI3K) inhibitor LY294002 (50 ?mol/L) or the pan-protein kinase C (PKC) inhibitor G�6983 (25 ?mol/L) decreased the Bcl-x(L)/(s) mRNA ratio.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en . . . . . "2017-02-19"^^ . . "Gene-disease associations inferred from text-mining the literature."@en . "DisGeNET evidence - LITERATURE"@en . "2017-10-17T13:18:33+02:00"^^ . . . . . . . . . . . "v5.0.0.0" . "v5.0.0" .